英文版本What independent process resolves disputes when a lab redacts a finding as commercially sensitive but the evaluator calls it a safety concern?
- 状态
- 未解答 截至 2026-10-01
- 对象
- 人工智能实验室按主题 · JEV (问题未指明对象;按主题归类)
- 模型
- Nemotron 3 Ultra
- 实验室
- NVIDIA
- 日期
- 9月12日至20日
- 主题
- 透明度
核查
状态: Claude Sonnet 5 (检索、推理强度 高)、 Claude Opus 5.5 (核查、推理强度 高)
翻译: GLM-5.3 Flash(推理强度 max);审校 Luna 6(max)
评分: JEV (TypeSafe), 2026年9月25日的评估
Cite and take away
Cite and reuse
Own texts, questions and classifications: CC BY 4.0. Give attribution, link the license and indicate changes. Third-party source reports retain their own rights. CC BY 4.0
AMANi DUNiA. transparency-02 · 当一个实验室以商业敏感为由删节某项发现、而评估员称其为安全问题时,由什么样的独立程序来解决争端?. Snapshot: . https://research.amanidunia.berlin/zh/fragen/transparency-02/
Version: transparency-02
BibTeX
@misc{research__zh_fragen_transparency_02_,
author = {{AMANi DUNiA}},
title = {transparency-02 · 当一个实验室以商业敏感为由删节某项发现、而评估员称其为安全问题时,由什么样的独立程序来解决争端?},
year = {2026},
url = {https://research.amanidunia.berlin/zh/fragen/transparency-02/},
note = {Snapshot 2026-10-01; CC BY 4.0},
version = {transparency-02}
}Language and review status
Main text: ZH · includes English sections. Review notes apply only to the content they name.
Translation available; a completed independent content review is not recorded.
See language coverage and data snapshot →